BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27496417)

  • 1. Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014.
    Usarek P; Dobrzaniecka K; Szymanek-Majchrzak K; Sawicka-Grzelak A; Mlynarczyk A; Durlik M; Ciszek M; Paczek L; Chmura A; Kwiatkowski A; Mlynarczyk G
    Transplant Proc; 2016 Jun; 48(5):1411-3. PubMed ID: 27496417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
    Çıkman A; Parlak M; Bayram Y; Güdücüoğlu H; Berktaş M
    Afr Health Sci; 2016 Mar; 16(1):149-52. PubMed ID: 27358626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
    Araoka H; Baba M; Okada C; Abe M; Kimura M; Yoneyama A
    Int J Infect Dis; 2017 May; 58():18-21. PubMed ID: 28257816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017.
    Wang L; Zhou W; Cao Y; Yang C; Liu H; Chen T; Chen L
    Medicine (Baltimore); 2020 Feb; 99(8):e19250. PubMed ID: 32080131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
    Garrison MW; Anderson DE; Campbell DM; Carroll KC; Malone CL; Anderson JD; Hollis RJ; Pfaller MA
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2859-64. PubMed ID: 9124855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
    Juhász E; Pongrácz J; Iván M; Kristóf K
    Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
    Duan Z; Qin J; Liu Y; Li C; Ying C
    BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
    Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
    J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
    Wang CH; Yu CM; Hsu ST; Wu RX
    J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
    Wu RX; Yu CM; Hsu ST; Wang CH
    J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
    Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
    J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of Stenotrophomonas maltophilia in asymptomatic lung transplant recipients: effects of treatment on eradication and outcome.
    Hofmann P; Hombach M; Seifert B; Schuurmans MM; Bürgi U; Isenring B; Mueller NJ; Kohler M; Benden C; Huber LC
    Clin Transplant; 2016 Aug; 30(8):857-63. PubMed ID: 27219076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of multidrug resistant environmental isolates of
    Govender R; Amoah ID; Kumari S; Bux F; Stenström TA
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2021; 56(2):213-225. PubMed ID: 33378222
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.
    Falagas ME; Valkimadi PE; Huang YT; Matthaiou DK; Hsueh PR
    J Antimicrob Chemother; 2008 Nov; 62(5):889-94. PubMed ID: 18662945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
    Nys C; Cherabuddi K; Venugopalan V; Klinker KP
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427300
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
    Palioura S; Gibbons A; Miller D; OʼBrien TP; Alfonso EC; Spierer O
    Cornea; 2018 Mar; 37(3):326-330. PubMed ID: 29408828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
    Wei C; Ni W; Cai X; Zhao J; Cui J
    PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
    Usta E; Eroğlu C; Yanık K; Karadağ A; Güney AK; Günaydın M
    Mikrobiyol Bul; 2015 Jan; 49(1):35-46. PubMed ID: 25706729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
    Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe cellulitis/myositis caused by Stenotrophomonas maltophilia.
    Downhour NP; Petersen EA; Krueger TS; Tangella KV; Nix DE
    Ann Pharmacother; 2002 Jan; 36(1):63-6. PubMed ID: 11816260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.